Interrupting signals exchanged between tumors and the nervous system could become a critical pillar of cancer care ...

Two new studies represent a big step toward developing innovative molecular therapies capable of disrupting the ...

A type of aggressive, treatment-resistant brain tumor has a distinct population of immune cells that support its growth, ...

Doug Kellogg, professor of molecular, cell, and developmental biology at UC Santa Cruz, has been awarded $2.95 million from ...

Cancer cells have special adaptation mechanisms that allow them to proliferate despite changes in their genetic makeup.

Scientists discovered a molecular switch that may reverse cancer cells, stopping them from growing abnormally.

Researchers at the Harvard Medical School discovered that the enzyme GUK1 promotes lung cancer growth by boosting the ...

Changes to the intermediate filament (IF) protein, vimentin, were found to promote tumor growth by increasing cancer stemness in an oestrogen independent manner. Targeting vimentin and/or the long ...

By activating a signaling protein called YAP (yes-associated protein, a transcription factor normally involved in stem cell maintenance and growth promotion) in combination with HPV oncogenes (genes ...

Findings indicate that altering glucose metabolism in T cells boosts their therapeutic potential against melanoma, paving the way for improved immunotherapies.

The small-molecule discovery could help in overcoming cell culture bottlenecks such as rapid degradation and high production costs.

Discover the latest in global connectivity with Starlink, American Tower, and Crown Castle. Click for more on my top picks ...